These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 11790173)

  • 21. [Systemic sclerosis].
    Tamborrini G; Distler M; Distler O
    Med Monatsschr Pharm; 2008 May; 31(5):162-70; quiz 171-2. PubMed ID: 18552072
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hematopoietic stem cell transplantation for systemic sclerosis: history and current status.
    Burt RK; Milanetti F
    Curr Opin Rheumatol; 2011 Nov; 23(6):519-29. PubMed ID: 21857226
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Treatment of scleroderma].
    Mouthon L
    Rev Prat; 2002 Nov; 52(17):1915-7. PubMed ID: 12532869
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bone marrow transplantation in the treatment of systemic sclerosis.
    Viganego F; Nash R; Furst DE
    Curr Rheumatol Rep; 2000 Dec; 2(6):492-500. PubMed ID: 11123103
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Systemic and localized scleroderma.
    Chung L; Lin J; Furst DE; Fiorentino D
    Clin Dermatol; 2006; 24(5):374-92. PubMed ID: 16966019
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Systemic sclerosis. Which therapies?].
    Bettoni L
    Minerva Med; 2001 Apr; 92(2):121-7. PubMed ID: 11323574
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Autologous stem cell transplantation in systemic sclerosis].
    Henes JC; Wirths S; Kötter I
    Z Rheumatol; 2016 Oct; 75(8):762-769. PubMed ID: 27510996
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High dose immunotherapy with stem cell rescue in severe systemic sclerosis: an idea that is moving forward.
    Furst DE; Nash R; Sullivan KM; Saccardi R; McSweeney P
    J Rheumatol; 2004 Dec; 31(12):2331-5. PubMed ID: 15570631
    [No Abstract]   [Full Text] [Related]  

  • 29. Interstitial lung disease in systemic sclerosis: current and future treatment.
    Giacomelli R; Liakouli V; Berardicurti O; Ruscitti P; Di Benedetto P; Carubbi F; Guggino G; Di Bartolomeo S; Ciccia F; Triolo G; Cipriani P
    Rheumatol Int; 2017 Jun; 37(6):853-863. PubMed ID: 28063071
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nonmyeloablative stem cell transplant in a patient with advanced systemic sclerosis and systemic lupus erythematosus.
    Khorshid O; Hosing C; Bibawi S; Ueno N; Reveille J; Mayes MD; Champlin RE
    J Rheumatol; 2004 Dec; 31(12):2513-6. PubMed ID: 15570660
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Scleroderma: Pathogenesis, pathophysiology, and therapy].
    Imai H; Suzuki K
    Nihon Rinsho; 2006 Feb; 64 Suppl 2():446-9. PubMed ID: 16523931
    [No Abstract]   [Full Text] [Related]  

  • 32. [Current treatment of systemic sclerosis. Part I. Immunosuppressive treatment].
    Sicińska J; Rudnicka L
    Pol Merkur Lekarski; 2008 Aug; 25(146):192-5. PubMed ID: 18942346
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Management of patients with systemic sclerosis].
    Wiesik-Szewczyk E; Olesińska M
    Pol Merkur Lekarski; 2010 May; 28(167):421-3. PubMed ID: 20568411
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Systemic sclerosis.
    Ng SC
    Singapore Med J; 1992 Apr; 33(2):189-92. PubMed ID: 1621127
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug treatment of scleroderma.
    Leighton C
    Drugs; 2001; 61(3):419-27. PubMed ID: 11293650
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Autologous Stem cell Transplantation International Scleroderma (ASTIS) trial: hope on the horizon for patients with severe systemic sclerosis.
    van Laar JM; Farge D; Tyndall A
    Ann Rheum Dis; 2005 Oct; 64(10):1515. PubMed ID: 16162905
    [No Abstract]   [Full Text] [Related]  

  • 37. Diffuse and limited cutaneous systemic scleroderma.
    Foeldvari I
    Curr Opin Rheumatol; 2000 Sep; 12(5):435-8. PubMed ID: 10990182
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Therapeutic possibilities in systemic scleroderma].
    Sönnichsen N; Brenke A
    Z Arztl Fortbild (Jena); 1992 Mar; 86(5):227-30. PubMed ID: 1585676
    [No Abstract]   [Full Text] [Related]  

  • 39. Efficacy and safety of autologous haematopoietic stem cell transplantation in systemic sclerosis: a systematic review of the literature.
    Eyraud A; Scouppe L; Barnetche T; Forcade E; Lazaro E; Duffau P; Richez C; Seneschal J; Truchetet ME;
    Br J Dermatol; 2018 Mar; 178(3):650-658. PubMed ID: 28906550
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autologous non-myeloablative haemopoietic stem-cell transplantation compared with pulse cyclophosphamide once per month for systemic sclerosis (ASSIST): an open-label, randomised phase 2 trial.
    Burt RK; Shah SJ; Dill K; Grant T; Gheorghiade M; Schroeder J; Craig R; Hirano I; Marshall K; Ruderman E; Jovanovic B; Milanetti F; Jain S; Boyce K; Morgan A; Carr J; Barr W
    Lancet; 2011 Aug; 378(9790):498-506. PubMed ID: 21777972
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.